dacarbazine,doxorubicin,brentuximab vedotin,vinblastine,bleomycin,vincristine
seagen
[]
hd21 ghsg rct
- pet-adapted
- 1500 patients from 9 countries
- powered for superiority for treatment-related morbidity and for non-inferiority for efficacy
#17icml 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem